A rare case of a middle ear glomangioma.

SAGE Open Med Case Rep

Department of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, MO, USA.

Published: January 2022

Glomus tumors are benign hyperplasia of glomus bodies, and they are rarely found in the head and neck. The middle ear is an exceptionally rare site for a true glomus tumor, and there are only three previously reported cases in this location. Glomus tumors are etiologically different than glomus tympanicum, which are paragangliomas of the middle ear that are often mistakenly referred to as "glomus tumors." This is a common misconception due to the "glomus" misnomer. We report a case of a patient diagnosed with a middle ear glomangioma after initially presenting to our clinic with tinnitus and hearing loss. The mass was surgically removed through a transcanal approach with carbon dioxide laser and sharp dissection. Literature review is also reported and revealed similar presentations in patients with middle ear glomangiomas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744075PMC
http://dx.doi.org/10.1177/2050313X211070520DOI Listing

Publication Analysis

Top Keywords

middle ear
20
ear glomangioma
8
glomus tumors
8
middle
5
ear
5
glomus
5
rare case
4
case middle
4
glomangioma glomus
4
tumors benign
4

Similar Publications

Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in asthma management remain limited. This registry-based study evaluated the use of montelukast in adult asthma patients, examining demographic and disease characteristics, asthma control status, asthma phenotypes, presence of atopy, and treatment regimens. Among 2053 patients analyzed, 61.

View Article and Find Full Text PDF

The 22q11.2 deletion is a risk factor for multiple psychiatric disorders including schizophrenia and also increases vulnerability to middle-ear problems that can cause hearing impairment. Up to 60% of deletion carriers experience hearing impairment and ~30% develop schizophrenia in adulthood.

View Article and Find Full Text PDF

Nondestructively-measured leaf ammonia emission rates can partly reflect maize growth status.

Plant Physiol Biochem

January 2025

School of Life Sciences, Anhui Agricultural University, Hefei 230036, China; Engineering Research Center of Environmentally-friendly and Efficient Fertilizer and Pesticide of Anhui Province, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China. Electronic address:

A deep understanding of ammonia (NH) emissions from cropland can promote efficient crop production. To date, little is known about leaf NH emissions because of the lack of rapid detection methods. We developed a method for detecting leaf NH emissions based on portable NH sensors.

View Article and Find Full Text PDF

Objective: To observe the clinical efficacy of electroacupuncture combined with ear tip bloodletting for insomnia with phlegm-fire disturbing heart.

Methods: A total of 60 cases with insomnia of phlegm-fire disturbing heart were selected, and the treatment of electroacupuncture combined with ear tip bloodletting was delivered. Acupuncture was applied at Yintang (GV24), Shenting (GV24), Sishencong (EX-HN1) and bilateral Shenmen (HT7), Quchi (LI11), Zhaohai (KI6), Shenmai (BL62), Fenglong (ST40), Neiting (ST4), Yintang (GV24) and Shenting (GV24) were connected to electroacupuncture, continuous wave, 2 Hz in frequency.

View Article and Find Full Text PDF

Objective: To assess if patients with enlarged vestibular aqueduct (EVA) experience symptoms characteristic of other third mobile window disorders such as superior semicircular canal dehiscence syndrome (SCDS).

Study Design: Cross-sectional study.

Setting: Tertiary care center.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!